PUBLIC CONTRACT · 2022
06/03228.11/2022 - Brolucizumab 120 mg/ml Sol inj
- Contract value
- €53,238.00
- Signed on
- 19 September 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9575940PUBLISHED SUBJECT
06/03228.11/2022 - Aquisição de “Brolucizumab 120 mg/ml Sol inj Ser 0.165 ml Intravítreo.”
Parties involved
- Place of performance
- Portugal, Aveiro, Santa Maria da Feira
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Novartis Farma-Produtos Farmacêuticos, S.A · Tax ID 500063524
Values and timeline
- Contract price
- €53,238.00
- Procedure base price
- €53,238.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 23 November 2022
- Award date
- 19 September 2022
- Signing date
- 19 September 2022
- Performance period
- 120 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/49 - Medicamentos usados nas afeções oculares e otorrinolaringológicas
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6053219
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.